This Marketstrat research report analyzes the world market for Interventional Cardiology Devices. The report discusses key players and identifies trends impacting the market for these products. Topics covered include product definitions, strategies, competitive analysis, key market and product segment parameters, market shares, competitive position maps, market conditions, brands and models, and company profiles. The report provides detailed market estimates and forecasts for interventional cardiology devices by product segment, separately for the USA, Canada, LATAM, Germany, France, UK, Italy, Japan, China, India and the Rest of the World (ROW). Market Forecasts (Revenues in US $ and and Units, 2010 – 2018

1. Interventional Cardiology Devices
Markets WorldwideMarkets Worldwide
Report Highlights
October 2011

2. Report Benefits
This report can help in:
• Assessing the market for Interventional Cardiology Devices
worldwide, growth segments, and growth regions.
• Understanding market drivers and restraints, market• Understanding market drivers and restraints, market
segmentation, and competitive segmentation.
• Strategic planning and competitive strategy.
• Identifying opportunities for partnerships and alliances.
2© 2011 Marketstrat, Inc., All Rights Reserved

3. Key Takeaways
• The world market for interventional cardiology devices comprised of coronary and carotid stents,
atherectomy devices, PTCA catheters, angiographic and guiding catheters is about $9.7 billion
growing at a CAGR of 8.7 percent over the next few years.
• Primary drivers include growing patient population and demand for PCI; new imaging technology
like IVUS that greatly enhances diagnosis and guidance; improving reimbursement and favorable
large-scale, long-term clinical studies and sky-rocketing demand in emerging healthcare markets.
• Primary restraints include post-treatment complications in the longer term, technical complexities• Primary restraints include post-treatment complications in the longer term, technical complexities
and availability of trained clinicians, and intense competition.
• Market opportunities include expansion in emerging markets, particularly China where growth of
many segments is between 20 to 30 percent; new technology launches including carotid stents, bio-
absorbable DES and devices for smaller vessels and peripheral artery disease.
• Leaders are Boston Scientific, Abbott Vascular, Cordis, Medtronic and ev3/ Covidien. Innovators
include Volcano Corp., Cardiovascular Systems Inc., Pathway Medical, Spectranetics, Reva Medical,
and Angioscore, among others.
October 11 3© 2011 Marketstrat, Inc., All Rights Reserved

4. Sample Data Table
JAPAN - DES CORONARY STENTS MARKET - REVENUE FORECASTS ($ Million, 2010-2018)
Year Revenues ($ Million) % of Japanese Mkt Growth (%)
2010 $433.24 39.90%
2011 $433.64 38.58% 0.09% 0.10%
2012 $434.06 37.23% 0.10% 0.11%
2013 $434.56 35.85% 0.11% 0.13%
2014 $435.07 34.46% 0.12% 0.15%
2015 $435.62 33.05% 0.13% 0.18%
© 2011 Marketstrat, Inc., All Rights Reserved 4
2015 $435.62 33.05% 0.13% 0.18%
2016 $436.25 31.62% 0.14% 0.21%
2017 $436.91 30.17% 0.15% 0.25%
2018 $437.62 28.72% 0.16% 0.33%
CAGR 0.1% 0.2%
Notes:
1. Includes drug-elutingcoronary stents
2. Data are at the manufacturer level
Source: Marketstrat®

5. Sample Data Table
World - ATHERECTOMY DEVICES -Revenue Forecasts by Country/Region - 2010-2018 ($ Mill)
Segment 2010 2011 2012 2013 2014 2015 2016 2017 2018 CAGR
USA
% of world market
CANADA
% of world market
LATAM
% of world market
FRANCE
% of world market
GERMANY
% of world market
UK
© 2011 Marketstrat, Inc., All Rights Reserved 5
UK
% of world market
ITALY
% of world market
JAPAN
% of world market
CHINA
% of world market
INDIA
% of world market
ROW
% of world market
TOTAL ($ Mill)
GROWTH (%)
2. Data a re a t the ma nufacturer level
Source: Marketstrat®
Notes :
1. Includes rota tiona l, excisional a nd la ser corona ry a therectomy devices

6. Sample Data Chart
WORLD - CAROTID STENTS MARKET - REVENUE FORECASTS (2010-2018, $ MILL)
12.0%
14.0%
16.0%
18.0%
20.0%
$8,000.0
$10,000.0
$12,000.0
%Growth
Revenues($Million)
© 2011 Marketstrat, Inc., All Rights Reserved 6
0.0%
2.0%
4.0%
6.0%
8.0%
10.0%
12.0%
$0.0
$2,000.0
$4,000.0
$6,000.0
$8,000.0
2010 2011 2012 2013 2014 2015 2016 2017 2018
%Growth
Revenues($Million)
Revenues ($ Mill) Growth (%)

7. Report Stats
Category Detail
Regions Covered United States; Canada; LATAM, Germany, France, UK, Italy,
Japan, China, India; Rest of the World (ROW)
Product/Market
Segments
• Coronary Stents – Drug Eluting (DES) and Bare Metal(BMS)
• Carotid Stents
• Atherectomy devices
• PTCA (percutaneous transluminal coronary angioplasty)
balloon catheters – Monorail/ rapid exchange (Rx) and Over-balloon catheters – Monorail/ rapid exchange (Rx) and Over-
the-wire (OTW)
• Angiography and Guiding Catheters
Company Profiles 110+ Companies
Market Estimates/
Forecasts
2010-2018
Report Code 325-11
Price $2995 (single-user license); $5990 (corporate license)
No. of Pages 474 pages; 230 data tables; 222 charts
Publication Date October 2011
© 2011 Marketstrat, Inc., All Rights ReservedOctober 11 7

8. About Us
Marketstrat specializes in Medical Market Research. We assist companies
with market, technology, and best practice strategies & intelligence,
through a unique combination of published reports, solutions, and
services.
Our strengths include: a deep understanding of the medical devices valueOur strengths include: a deep understanding of the medical devices value
chain, state-of-the-art data collection tools, and a robust research
methodology.
4695 Chabot Drive, Suite 200
Pleasanton, CA 94588, USA.
Email : info@marketstrat.com
Phone: 925-263-4455
Fax: 925-263-4456
www.marketstrat.com
October 11 © 2011 Marketstrat, Inc., All Rights Reserved 8

9. October 11 9© 2011 Marketstrat, Inc., All Rights Reserved